Testing effectiveness (Phase 2)UnknownNCT04163419
What this trial is testing
Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis
Who this might be right for
SchwannomatosisPain
Massachusetts General Hospital 9
Showing 20 of 0 results